Lactoferrin in the treatment of diabetes mellitus
US7034126B2 · kind B2 · utility
2Cited by
12References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2004 |
| Grant date | Apr 25, 2006 |
| Priority date | — |
| Expiry date | May 13, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of using a composition of lactoferrin for the treatment of diabetes mellitus as manifested by a reduction in the levels of serum glucose, blood pressure, obesity, or glycosylated hemoglobin (HbAlc).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.